Glycomics, parking
momentapharma.com
Alan L. Crane MBA
Chairman and CEO
Mr. Crane was previously Senior Vice President, Global Corporate Development, at Millennium Pharmaceuticals where he was responsible for leading Millennium's strategic partnering, mergers and acquisitions, and licensing activities. During his tenure, Mr. Crane built one of the industry's leading corporate development groups, forged strategic alliances that brought over $2 billion of funding to Millennium, and licensed or acquired 19 products. Previously, Mr. Crane was a marketing executive at Dupont-Merck and a consultant with the Boston Consulting Group and Arthur D. Little.
Steven Brugger, MBA
Vice President, Strategic Product Development
Mr. Brugger was previously Vice President at Millennium Pharmaceuticals where he built strategic marketing, project and portfolio management, led the inflammation and metabolic franchises, and managed multiple pharmaceutical collaborations. Prior to this, Mr. Brugger spent 19 years in the pharmaceutical industry, holding positions in product development and marketing at Hoechst, Ayerst, and Novartis. His most recent position was as Head of Marketing for the Novartis Specialty Business Unit, responsible for US marketing of Sandimmune®/Neoral®, the company's leading worldwide pharmaceutical brand.
Ian Fier, MBA
Senior Director, Development Operations
Mr. Fier was previously Vice President at BioTransplant, Inc. where he was responsible for product development and clinical affairs. Prior to that, Mr. Fier worked at The Medicines Company, where he built the development organization and managed the clinical development of bivalirudin (Angiomax®) through regulatory approval. In this role, he was responsible for overseeing several large clinical trials in acute coronary syndrome. Mr. Fier has also held various product development positions at Hoechst and Astra.
Joseph E. Tyler
Vice President, Manufacturing
Dr. Tyler was previously Vice President, Operations at Salix Pharmaceuticals, Inc., where he was responsible for new product manufacturing development and managed supply chain operations encompassing five manufacturing sites. Previously, he was Vice President of Manufacturing at Gel-Tex and held positions in process development and manufacturing at Abbott, Lederle and Schering AG.
Ganesh Venkataraman Ph.D.
Founder & Vice President, Technology
Dr. Venkataraman is one of Momenta's scientific founders. Prior to founding Momenta, Dr. Venkataraman was at MIT where he pioneered research in the area of analytical techniques for complex carbohydrates. He also served as the Director of Bioinformatics for the Consortium for Functional Glycomics, a multi-million dollar NIH initiative to study the role of complex sugars in biology.
Susan K. Whoriskey, Ph.D.
Vice President, Licensing and Business Development
Dr. Whoriskey joined Momenta at its inception. Previously, she was Senior Director of Licensing at Cubist Pharmaceuticals, Inc., where she was involved in negotiating collaborations with Merck, Pfizer, Novartis and Bristol Myers Squibb as well as the in-licensing of the company's key product from Eli Lilly, daptomycin. She was also responsible for oversight of the company's intellectual property estate. |
